- Patent Title: Methods for determining drug response of patient specific mutations
-
Application No.: US15327499Application Date: 2015-07-20
-
Publication No.: US10550439B2Publication Date: 2020-02-04
- Inventor: Gabi Tarcic , Yoram Altschuler
- Applicant: NOVELLUSDX LTD.
- Applicant Address: IL Jerusalem
- Assignee: NovellusDX Ltd.
- Current Assignee: NovellusDX Ltd.
- Current Assignee Address: IL Jerusalem
- Agency: Cooley LLP
- International Application: PCT/IL2015/050746 WO 20150720
- International Announcement: WO2016/013007 WO 20160128
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6897 ; C12Q1/6886
Abstract:
Methods for identifying and determining drug response of patient specific oncogenic mutations are provided. The methods provided identify specific (personalized) drug treatment based on the effect of drug on the patient derived markers associated with aberrant signal transduction pathways, in biological samples of a cancer patient.
Public/Granted literature
- US20170159137A1 METHODS FOR DETERMINING DRUG RESPONSE OF PATIENT SPECIFIC MUTATIONS Public/Granted day:2017-06-08
Information query
